|
CXCR4 Antagonists for the Treatment of Cancer
Application
Small molecules containing either the piperidine or piperazine core which act as antagonists to C-X-C chemokine receptor type 4 (CXCR4) and may be orally administered.
Key Benefits
Orally administered CXCR4 antagonists with diverse clinical applications in oncology.
Mobilize white blood cells in mice in a dose-dependent manner.
Cause...
Published: 4/23/2024
Contributor(s): Lawrence (larry) Wilson, Dennis Liotta, John Wiseman, Michael Natchus
|